View in EDS

57MO First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in HR+/HER2− advanced breast cancer (ABC): A post hoc analysis of Asian and non-Asian patients (pts) from the phase II RIGHT choice trial.

Saved in:
Bibliographic Details
Title: 57MO First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in HR+/HER2− advanced breast cancer (ABC): A post hoc analysis of Asian and non-Asian patients (pts) from the phase II RIGHT choice trial.
Authors: Yap, Y-S.1 (AUTHOR), Im, S-A.2 (AUTHOR), Lu, Y-S.3 (AUTHOR), Azim, H.A.4 (AUTHOR), Eralp, Y.5 (AUTHOR), Kanakasetty, G.B.6 (AUTHOR), Abdel-Razeq, H.7 (AUTHOR), Zhukova, L.8 (AUTHOR), Thuerigen, A.9 (AUTHOR), Delgar Alfaro, T.10 (AUTHOR), Wu, J.11 (AUTHOR), Gao, M.12 (AUTHOR), El Saghir, N.S.13 (AUTHOR)
Source: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1488-S1488. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 173758075
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 57MO First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in HR+/HER2− advanced breast cancer (ABC): A post hoc analysis of Asian and non-Asian patients (pts) from the phase II RIGHT choice trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Yap%2C+Y-S%2E%22">Yap, Y-S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Im%2C+S-A%2E%22">Im, S-A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lu%2C+Y-S%2E%22">Lu, Y-S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Azim%2C+H%2EA%2E%22">Azim, H.A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eralp%2C+Y%2E%22">Eralp, Y.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kanakasetty%2C+G%2EB%2E%22">Kanakasetty, G.B.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdel-Razeq%2C+H%2E%22">Abdel-Razeq, H.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhukova%2C+L%2E%22">Zhukova, L.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Thuerigen%2C+A%2E%22">Thuerigen, A.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Delgar+Alfaro%2C+T%2E%22">Delgar Alfaro, T.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+J%2E%22">Wu, J.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gao%2C+M%2E%22">Gao, M.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22El+Saghir%2C+N%2ES%2E%22">El Saghir, N.S.</searchLink><relatesTo>13</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 4, Vol. 34, pS1488-S1488. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173758075
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2023.10.192
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S1488
    Titles:
      – TitleFull: 57MO First-line (1L) ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in HR+/HER2− advanced breast cancer (ABC): A post hoc analysis of Asian and non-Asian patients (pts) from the phase II RIGHT choice trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yap, Y-S.
      – PersonEntity:
          Name:
            NameFull: Im, S-A.
      – PersonEntity:
          Name:
            NameFull: Lu, Y-S.
      – PersonEntity:
          Name:
            NameFull: Azim, H.A.
      – PersonEntity:
          Name:
            NameFull: Eralp, Y.
      – PersonEntity:
          Name:
            NameFull: Kanakasetty, G.B.
      – PersonEntity:
          Name:
            NameFull: Abdel-Razeq, H.
      – PersonEntity:
          Name:
            NameFull: Zhukova, L.
      – PersonEntity:
          Name:
            NameFull: Thuerigen, A.
      – PersonEntity:
          Name:
            NameFull: Delgar Alfaro, T.
      – PersonEntity:
          Name:
            NameFull: Wu, J.
      – PersonEntity:
          Name:
            NameFull: Gao, M.
      – PersonEntity:
          Name:
            NameFull: El Saghir, N.S.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 11
              Text: 2023 Supplement 4
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 34
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1